Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	13.98	52.17	45.77
Graham Fair Price	7.99	2.40	2.22
PEG	260.02	-0.88	0.24
Price/Book	-4.10	0.93	0.97
Price/Cash Flow	-61.50	16.82	43.68
Prices/Earnings	-17.58	26.86	32.59
Price/Sales	-0.28	4.59	4.60
Price/FCF	-61.50	16.82	43.68
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	7.98	0.25	0.23
Operating Margin	71.33	0.12	0.07
ROA	18.07	< 0.005	< 0.005
ROE	< 0.005	< 0.005	16.35
ROIC	< 0.005	< 0.005	29.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	-0.06	55.95
Dividends QOQ	-0.28	0.38	35.59
EBIT QOQ	-0.19	0.64	241.84
EPS QOQ	1.33	-0.30	-77.11
FCF QOQ	-0.44	1.48	238.49
Revenue QOQ	< 0.005	-0.04	340.32
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	31.31	32.88	5.03
Days Sales Outstanding (DSO)	121.69	120.74	-0.79
Inventory Turnover	2.87	2.74	-4.79
Debt/Capitalization	0.53	0.55	4.69
Quick Ratio	0.76	0.80	5.60
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.45	5.45	0.11
Cash	2.05	1.76	-14.41
Capex	-0.10	-0.07	31.16
Free Cash Flow	0.12	0.30	149.38
Revenue	1.14	1.10	-3.72
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.04	1.17	12.70
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.96	26.67	27.29
Naive Interpretation	Member

06 - Financial Health · Bad

Rating